Solid organ transplant recipient attitudes towards a SARS-CoV-2 vaccine
Michael T. Ou(Johns Hopkins University), Jacqueline Garonzik‐Wang(University of Wisconsin–Madison), Laura B. Zeiser(Johns Hopkins University), Jennifer Martin, Teresa Po‐Yu Chiang(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Dorry L. Segev(New York University), Sarah E. Van Pilsum Rasmussen(Johns Hopkins University), Jake A. Ruddy(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Michael Cooper, Jennifer St. Clair Russell(National Kidney Foundation), Robin K. Avery(Johns Hopkins University), Brian J. Boyarsky(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore)
American Journal of Transplantation
January 1, 2021
Cited by 0
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k